In vivo genotypic evolution of Klebsiella pneumoniae Sequence Type 512
ceftazidime-avibactam, meropenem-vaborbactam and cefiderocol therapies impacted on the resistome of sequence type (ST) 512 K. pneumoniae colonizing or infecting the patient during the hospitalization period